Skip to content

SEARCH

Investing News
Biotech
Oil & Gas
Health
Mining
Cannabis
Energy
Tech
Health
MORE

Search

SEARCH FOR AN ARTICLE

Search

Investing News
Biotech
Oil & Gas
Health
Mining
Cannabis
Energy
Tech
Health
MORE

HomeEli Lilly & Co.

Eli Lilly & Co.

Eli Lilly Secures FDA Approval for Obesity Drug Competing with Wegovy and Ozempic

Eli Lilly Secures FDA Approval for Obesity Drug Competing with Wegovy and Ozempic

November 8, 2023

LATEST NEWS

Investing News Apple’s Q4 Earnings Reveal Strong Revenue, Tax Charge Impact
Investing News Nvidia’s Stock Takes a Hit Amid AI Spending Concerns
Investing News Alphabet Earnings Report Faces Regulatory Headwinds
Investing News Chevron Q3 Earnings Analysis: Buy, Sell, or Hold?
Investing News Market Trends: Nasdaq’s Steady Rise

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from Micro Cap Watch.

I want e-mail alerts, updates, and offers and agree to the MicroCapWatch privacy policy.

Market Jar Media Inc. © 2024